Inventor
ZHENG XIUFANG
CN21 patents
⚠️ This page may combine multiple inventors who share the name “ZHENG XIUFANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
17 patentsUS9441008B2Sep 13, 2016
3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE13 citations92
US10618929B2Apr 14, 2020
3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE5 citations83
US10233184B2Mar 19, 2019
7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE12 citations83
US10040815B2Aug 7, 2018
3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE7 citations83
US9708325B2Jul 18, 2017
Sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE3 citations72
USRE49481EApr 4, 2023
Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
HOFFMANN LA ROCHE0 citations62
US11180525B2Nov 23, 2021
Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection
HOFFMANN LA ROCHE0 citations62
US10975098B2Apr 13, 2021
Substituted aminothiazolopyrimidinediones for the treatment of virus infection
HOFFMANN LA ROCHE0 citations62
US10590146B2Mar 17, 2020
Substituted aminothiazolopyrimidinediones
HOFFMANN LA ROCHE1 citations62
US8604019B2Dec 10, 2013
Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
HOFFMANN LA ROCHE2 citations62
US11242345B2Feb 8, 2022
Sulfonimidoylpurinone compounds and methods of treatment using the same
HOFFMANN LA ROCHE0 citations61
US10752630B2Aug 25, 2020
7-substituted sulfonimidoylpurinone compounds for the treatment of virus infection
HOFFMANN LA ROCHE0 citations51
US10399983B2Sep 3, 2019
Sulfonimidoylpurinone compounds
HOFFMANN LA ROCHE0 citations51
US10065973B2Sep 4, 2018
Substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE0 citations51
US10189838B2Jan 29, 2019
Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
HOFFMANN LA ROCHE0 citations41
US9890155B2Feb 13, 2018
Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
HOFFMANN LA ROCHE0 citations41
US9670211B2Jun 6, 2017
Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
HOFFMANN LA ROCHE0 citations41
UNIV SHANDONG
2 patentsUS12252444B1Mar 18, 2025
Crack-resistant ultra-high performance concrete for underground engineering in water-rich strata, preparation method, and application thereof
UNIV SHANDONG1 citations57
US12305105B1May 20, 2025
Silane-modified penetration-resistant ultra-high-performance concrete, preparation method, and application thereof
UNIV SHANDONG0 citations56